Decoding Wockhardt's Spectacular Surge: Can WCK5222 Propel Further Growth? | Buy Now Sell Now Lens

On this edition of BNSN Lens, we zoomed in on the spectacular move for Wockhardt move. The stock zoomed over 35% this week and about 90% in the last one month. What are the key levers for growth? Is WCK5222 a game-changer for the company? What does their launch pipeline look like? Srishti Sharma decodes the valuation potential the company's two promising drugs present.
What is the growth potential Habil Khorakiwala, Founder and Chairman envisage from the drug? Listen in to a slice of our conversation with him last week.
Against this backdrop, should you ride the wave when it comes to Wockhardt? We also got our experts Kunal Bothra, kunalbothra.co.in and Vivek Karwa , VRIDHI Investment to get their views on the path ahead for the stock.
#wockhardt #pharmaceuticals #stockmarket #wck5222 #buynowsellnowlens #etnow #businessnews #topnews #trending
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► goo.gl/SEjvK3
Subscribe Now To Our Network Channels :-
Times Now : goo.gl/U9ibPb
The NewsHour Debate : goo.gl/LfNgFF
To Stay Updated Download the Times Now App :-
Android Google Play : goo.gl/zJhWjC
Apple App Store : goo.gl/d7QBQZ
Social Media Links :-
Twitter - goo.gl/hA0vDt
Facebook - goo.gl/5Lr4mC
G+ - goo.gl/hYxrmj
Website - www.etnownews.com